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Abstract
Background: The Schizophrenia Caregiver Questionnaire (SCQ) was developed to assess the impact on caregivers
of caring for patients with schizophrenia. The objective of this study was to develop a scoring algorithm for the
SCQ, and evaluate its measurement properties.
Methods: The SCQ was administered to 358 caregivers of patients with schizophrenia included in the observational
PATTERN study of stabilized patients with persistent symptoms of schizophrenia receiving outpatient care. SCQ item
selection and creation of scores were based on exploration of item response distribution, factor analyses, and Rasch
model. Construct validity, reliability, and ability to detect change of the SCQ scores were investigated.
Results: The final questionnaire comprised a ‘Humanistic impact’ supra-domain composed of a global score and four
subdomain scores (‘Physical’; ‘Emotional’; ‘Social’; ‘Daily life’), and eight other domain scores related to the caregiving role
(‘Exhaustion with caregiving’; ‘Feeling alone’; ‘Patient Dependence’; ‘Worries for the patient’; ‘Perception of caregiving’;
‘Financial dependence of the patient’; ‘Financial impact of caregiving’; ‘Overall difficulty of caregiving’). Two items from
the SCQ were deleted. SCQ scores showed very good construct validity: Item convergent/discriminant validity were
satisfactory; SCQ scores of caregivers of patients with more severe symptoms were higher indicating more impact
(p < 0.05 for all scores); SCQ scores were meaningfully associated with measures of schizophrenia severity (PANSS
and PSP) and caregivers’ Health-Related Quality of Life (Medical Outcome Survey Short Form 36 items). The SCQ
Humanistic impact supra-domain scores demonstrated very good internal consistency reliability (Cronbach’s
alphas between 0.80 and 0.96) and test-retest reliability (Intraclass Coefficient correlations ranging from 0.75 and 0.87);
Other SCQ domain scores showed lower but still acceptable reliability coefficients. SCQ scores clearly increased for
caregivers of patients whose schizophrenia worsened.
Conclusions: Overall, the 30-item SCQ demonstrated very good measurement properties supporting its relevance to
comprehensively measure the experience of caregivers of patients with schizophrenia.
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Background
Schizophrenia is a severe mental illness that affects be-
tween 0.3 and 0.7 % of the adult population worldwide
and is considered a leading cause of disability [1]. Over
the years, there has been a shift of care from psychiatric
hospitals to outpatient treatment, community services,
and informal caregivers. It is estimated that 50 to 90 %
of people with a chronic psychiatric illness live with their
families or friends [2, 3]. Caregivers, particularly infor-
mal caregivers, are defined as persons who have signifi-
cant responsibility for managing the well-being of a
person diagnosed with schizophrenia in an unpaid cap-
acity. Caregivers provide an important service by redu-
cing the need for formal care and the burden upon
healthcare systems [4].
Even if caring for a person with schizophrenia may be
considered a fulfilling and positive experience for some
[5], it is also frequently associated with a negative impact
on multiple aspects of a caregiver’s life. The impact of
caregiving for a person with schizophrenia is a multidi-
mensional concept, consisting of social, physiological,
behavioral, functional, mental, medical and economic
domains [6, 7]. Behavioral family management, psy-
choeducational family intervention, and family therapy
have been shown to improve caregiver coping skills and
reduce the impact of caregiving [8]. For example,
Magliano et al. demonstrated that a psychoeducational
family intervention contributed to improvements in
caregivers’ experiences, especially in regards to coping
with schizophrenia-related stigma [9].
The Zarit Burden Interview (ZBI) is a 22-item instru-
ment which aims to assess the impact level experienced
by a caregiver for an individual with dementia or disabil-
ities [10]. The ZBI has been used in several studies
investigating the impact of caregiving on caregivers for
individuals with diverse conditions, including schizo-
phrenia [11, 12]. However, as a generic measure, it is not
specific to schizophrenia. Therefore the Schizophrenia
Caregiver Questionnaire (SCQ) was recently developed
as an adaptation of the ZBI to provide a comprehensive
assessment of the impact of caregiving for an individual
with schizophrenia [13]. The SCQ development process
included a literature review and face to face open-ended,
semi-structured, qualitative interviews with 19 US-English
speaking caregivers of patients with schizophrenia [7, 13].
The concept elicitation part of the interviews showed that
caring for a person with schizophrenia placed a significant
impact on emotional, physical and financial lives of care-
givers, as well as on their daily activities and relationships.
The cognitive debriefing part confirmed the appropriate-
ness and understanding by caregivers of the pilot version
of the SCQ. Notable differences between the SCQ and
ZBI included the specification of a recall period of ‘during
the past 4 weeks’, the utilization of an 11-point numerical
rating scale for all items, and additional questionnaire
items. Moreover, the wording of some items was adapted
to ensure that the questionnaire addressed issues of
importance to caregivers of patients with schizophrenia.
In addition, the cultural aspects of the measurement of
impact on caregiver by the SCQ were explored, in the
context of a linguistic validation of the questionnaire in 11
European languages to allow for the reliable pooling of
data gathered by all language versions [14]. The linguistic
validation included concept definition, back and forward
translations, and cognitive interviews with 55 caregivers
of patients with schizophrenia, five per language. Few
respondents raised specific cultural concerns or diffi-
culties leading to modifications in the translated version
of the SCQ.
The pilot version of the SCQ was included in the
PATTERN study, an observational study conducted to
describe the course of illness for patients with persistent
symptoms of schizophrenia [15]. The present analysis
aimed to define the scoring algorithm for the newly devel-
oped SCQ that could help to better understand the diverse
aspects of caregiver’s experience, and to investigate its
measurement properties to ensure that it is a valid and
appropriate instrument for use in future studies to assess




The PATTERN study (ClinicalTrials.gov Identifier: NCT01
634542) is an international, multicenter, non-interventional,
prospective study of stabilized patients with persistent
symptoms of schizophrenia receiving outpatient care [15].
The primary objective was to describe the course of illness
for patients with persistent symptoms of schizophrenia.
The assessment of the emotional and economic impact
and health-related quality of life (HRQL) in caregivers
was a secondary objective. Patients included in the study
were ≥18 years of age and diagnosed with schizophrenia
according to DSM-IV-TR or International Classification of
Diseases, 10th revision, documented with the Mini Inter-
national Neuropsychiatric Inventory, of ≥ 12 months dur-
ation before the baseline observation. Caregivers included
in the study were a family member/relative or significant
other/close friend ≥18 years of age spending more than
four hours a week with the patient. Caregivers accom-
panying a patient to the baseline visit were invited to
participate in the study. Once consented, caregivers
were invited to complete the SCQ and caregiver's global
impression scales (CaGI).
Assessments
The present analyses were performed using interim
data of the PATTERN study. The interim data included
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6 months of follow-up data. The caregiver data included
the SCQ and CaGI completed at baseline and at 3- and 6-
months, and the SF-36 completed only at baseline. The
pilot version of the SCQ consisted of 32 items to assess
the impact of care experienced by the caregivers of pa-
tients with schizophrenia with higher scores representing
higher impact. The hypothesized initial structure mea-
sured 12 domains: ‘Caregiver roles and responsibilities’;
‘Caregiver perception of patient dependence’; ‘Caregiver
perception of level of care they provide’; ‘Exhaustion with
caregiving role’; ‘Lack of support’; ‘Impact on caregiver’s
daily lives’; ‘Finances’; ‘Impact on social and financial life’;
‘Emotional’; ‘Physical’; ‘Concerns for future’ and ‘Present
concerns’. The CaGI severity (CaGI-S) is a scale com-
pleted by the caregiver to assess the severity of the
symptoms of schizophrenia experienced by the patient:
“Please rate the severity of his/her symptoms during
the past 4 weeks”. It is rated on a 6-point scale from 1
(no symptoms) to 6 (very severe symptoms). The CaGI
improvement (CaGI-I) is a scale for the caregiver to
rate the change in severity of symptoms of schizophrenia
from baseline: “Overall, how have his/her symptoms chan-
ged (if at all) since the beginning of the study (before start-
ing treatment)?” It is rated on a 7-point scale from 1 (very
much improved) to 7 (very much worse). The Medical
Outcome Survey Short-Form 36 items (SF-36) is a fre-
quently used generic scale to assess aspects of functioning
and physical and mental health [16].
Other data included the Positive and Negative Syndrome
Scale (PANSS), the Personal and Social Performance (PSP)
and the clinician global impression scales (CGI) at baseline
and the CGI at 3- and 6-months.
The PANSS is a 30 item, clinician completed scale
which assesses the severity of patient’s symptoms and is
informed by a clinical interview with patients and their
caregivers. In addition to the PANSS total or subdomain
scores, 5 factor scores can be calculated: negative
symptoms, positive symptoms, disorganized thought,
hostility/excitement and anxiety/depression [17]. The
PSP is a single-item clinician-rated 100-point scale enab-
ling the determination of small changes in levels of func-
tioning [18]. CGI-Severity (CGI-S) and CGI Improvement
(CGI-I) are 7-point clinician-rated scales to measure the
overall illness severity from 1 (normal) to 7 (among the
most severely ill) and change in symptom severity since
baseline scored from 1 (very much improved) to 7 (very
much worse) [19].
Analysis for the validation of the SCQ
The structure of the questionnaire was determined using
item response distributions and iterative confirmatory fac-
tor analysis (CFA). Fit of the CFA models was evaluated
with commonly used goodness-of-fit indices: Root Mean
Square Error of Approximation (RMSEA); Standardized
Root Mean Residuals (SRMR); Goodness of Fit Index
(GFI); Adjusted Goodness of Fit Index (AGFI); Normed
Fit Index (NFI); Comparative Fit Index (CFI). The most
stringent criteria for goodness-of-fit found in the literature
(RMSEA < 0.05; SRMR < 0.05; GFI > 0.90; AGFI > 0.90;
NFI > 0.94; CFI > 0.95) were considered [20]; however,
these criteria have been reported to potentially be too con-
servative [21]. CFA model fit was evaluated when a model
met some, but not all of these aforementioned criteria
demonstrating a consistently solid picture in terms of fit.
Iterative CFAs were applied on the item correlation matrix
obtained using SCQ data collected at baseline. The first
CFA was conducted using the original conceptual
framework composed of the SCQ’s 32 items grouped
into 12 domains. Then, a series of modifications were
made to the model to improve its quality in an iterative
approach. Items with low factor loadings were either
re-allocated to other domains or deleted from the
model. Then it was explored whether the SCQ items
could fit a Rasch model, to generate further information
that may be used to support decisions on the scoring of
the SCQ. A Rating Scale Model was tested for the Hu-
manistic impact supra-domain of the SCQ only, for which
a clear underlying unidimensional latent construct could
be hypothesized both theoretically and from the empirical
results of the CFA.
Construct validity (item concurrent and divergent val-
idity, concurrent and known-group validity), test-retest
and internal consistency reliability, and ability to detect
change were assessed. Concurrent validity was assessed
by Pearson correlation coefficients between SCQ scores
and SF-36, PANSS and PSP scores. Clinical validity was
assessed by comparing SCQ scores at baseline according
to patients’ disease severity assessed using CGI-S, and
CaGI-S. Internal consistency reliability of multi-item scores
was assessed by Cronbach’s alpha. Test-retest reliability was
assessed by interclass correlation coefficient (ICC) between
the completion of the SCQ at baseline and month 3 in
caregivers who rated the patient’s schizophrenia sever-
ity as unchanged. Ability of the SCQ to detect change
was assessed by comparing SCQ mean changes in
scores from baseline to month 6 according to groups
defined by responses to the CaGI-I (Improved group:
'very much improved', 'much improved' and ‘minimally
improved’; Stable group: 'no change’; Worsened group:
'minimally worse', 'much worse' and 'very much worse')
[22, 23]. Student t-tests or one-way ANOVAs were
used for the statistical comparisons.
Interpretation guides for the SCQ scores were estimated
using both distribution-based and anchor-based methods.
All analyses were performed using SAS statistical soft-
ware version 9.2 (SAS Institute, Cary, NC, USA), except
Rasch model for which RUMM 2030 (RUMM Laboratory,
Perth, Australia) was used.
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Results
Populations
A total of 385 caregivers were recruited in the PATTERN
study and among them, 358 had SCQ data. Mean age of
patients who were cared for by the included caregivers was
40.0 years. The majority of patients were male (67.6 %).
Most patients were rated as moderately (44.9 %) or mark-
edly ill (28.4 %) by their clinicians. From the caregivers’ per-
spective, 33.5 % of patients had moderate symptoms and
20.9 % had mild symptoms. Detailed demographic and clin-
ical characteristics of the patients are provided in Table 1.
Definition of scoring algorithm of the SCQ
Since responses to SCQ items were compulsory in the
electronic data collection system, there were no missing
data. A floor effect was observed for almost all items;
six items had over 50 % of caregivers giving the lowest
value on the response scale. As the initial model tested in
the CFA, which was based on the qualitative research and
included 12 domains, did not demonstrate a fully accept-
able fit (RMSEA: 0.08; SRMR: 0.07; GFI: 0.79; AGFI: 0.76;
NFI: 0.72; CFI: 0.87) alternative models were examined.
The results of the final CFA model of the SCQ are dis-
played in Fig. 1. Even though none of the goodness-of-fit
indices met the stringent criteria, considering the overall
picture of the fit indices, this final model was deemed
overall to be acceptable. Item 19 (“How often did you
feel uncertain about how to care for him/her?”)' and
item 26 (“How difficult was it to get him/her to take his/
her medication?”) were not retained in the SCQ as they
did not fit well within their domains with low factor
loadings and were deemed to capture concepts central
enough to warrant single-item scores. Items 1, 2, 6, 14
and 18 were retained in the questionnaire based on
qualitative assessment of their content, despite their im-
perfect fit to the model. Items 9 and 15 pertaining to fi-
nancial aspects were separated into two different single
item scores as they covered two distinct concepts.
A two component structure was sketched for the SCQ.
The first component, named ‘Humanistic impact’ supra-
domain, assesses the direct impact on the individual
caregiver and includes four subdomains (‘Humanistic
impact - Social’, ‘Humanistic impact - Emotional’, ‘Humanis-
tic impact - Daily Life’, and ‘Humanistic impact - Physical’)
plus an overall assessment (‘Humanistic Impact - Total
score’). The second part of the questionnaire assesses all
other aspects of the caregiver experience which does not
directly reflect its personal impact, including eight domains:
‘Overall difficulty of caregiving’; ‘Patient dependence’; ‘Per-
ception of caregiving’; ‘Exhaustion with caregiving’; ‘Feeling
alone’; ‘Financial dependence of the patient’; ‘Financial im-
pact of caregiving’; ‘Worries for the patient’.
A Rasch model was applied to the Humanistic Impact
supra-domain only. The 11-point rating scale led to
several disordered thresholds but recoding the responses
in fewer categories led to a model without any disordered
thresholds. Items 24 and 25 had residuals greater than 2.5
in absolute value, together with a non-significant chi-
square test, indicating poor fit to the model. The Person-
Item map resulting from this analysis is presented in Fig. 2.
SCQ items cover part of the latent trait (i.e., Humanistic
impact) on which most individuals are located. The map
Table 1 Description of baseline patient characteristics
corresponding to the caregiver analysis set (N = 358)
Characteristics Patients
(n = 358)
Age (years), Mean (SD) 40.0 (11.6)
Gender, n (%) Male 242 (67.6)






United Kingdom 29 (8.1)
Italy 107 (29.9)
Smoking status, n (%) Current smoker 152 (42.5)
Never smoked 162 (45.2)
Past smoker 43 (12.0)
PSP, Mean (SD) Global score 49.8 (19.2)
PANSS, Mean (SD) Negative symptoms 24.7 (7.3)
Positive symptoms 23.3 (8.0)
Disorganized thought 19.4 (6.1)
Uncontrolled hostility/Excitement 8.2 (3.9)
Anxiety/Depression 10.5 (3.9)
Total 86.1 (23.4)
CGI-S, n (%) Normal 6 (1.7)
Minimally ill 19 (5.3)
Mildly ill 57 (16.0)
Moderately ill 160 (44.9)
Markedly ill 101 (28.4)
Severely ill 12 (3.4)
Among the most severely ill 1 (0.3)
CaGI-S, n (%) No symptoms 50 (14.1)
Very mild symptoms 68 (19.2)
Mild symptoms 74 (20.9)
Moderate symptoms 119 (33.5)
Severe symptoms 40 (11.3)
Very severe symptoms 4 (1.1)
PSP Personal and Social Performance Scale, PANSS Positive and Negative
Syndrome Scale, CGI-S Clinician Global Impression – Severity, CGI-S Caregiver
Global Impression – Severity
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also shows that the locations corresponding to very high
Humanistic impact (at the extreme right end of the x-
axis) and mild impact (at the extreme left end of the
x-axis) are not adequately covered by SCQ items.
While the former corresponds to only a handful of indi-
viduals, there were about one third of caregivers for whom
the Humanistic impact was absent or too mild to be ac-
curately captured by the SCQ items.
Based on the observation of response distribution and
results of the Rasch model, responses were recoded to a
0 to 4 scale as follows: 0-1 responses were recoded to 0;
2-3-4 to 1; 5-6 to 2; 7-8 to 3; 9-10 to 4. Scores of the
SCQ were obtained by a sum of the recoded item scores,
linearly transformed to a 0 to 100 range. Higher scores
indicated greater impact.
Assessment of measurement properties of the SCQ
Reliability
SCQ domain scores are described at baseline in Table 2,
together with results for reliability assessment. For al-
most all SCQ domain scores, Cronbach’s alpha and ICC
demonstrated very good reliability.
Fig. 1 CFA results of the final model of the SCQ linking items, concepts, and the total “Humanistic impact” at baseline in the caregiver analysis
set (N = 358); RMSEA: Root Mean Square Error of Approximation; SRMR: Standard Root Mean square Residuals; GFI: Goodness of Fit Index;
AGFI: Adjusted Goodness of Fit Index; NFI: Normed Fixed Index; CFI: Comparative Fit Index
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Construct validity
The SCQ domain structure was supported by good item
convergent and discriminant validity (Table 2). All items
met the item convergent validity criterion (i.e., were well
correlated with their own dimension), except for the ‘Pa-
tient dependence’ domain (0.37). The four scores exploring
different aspects of humanistic impact had imperfect item
discriminant validity, probably due to the strong association
between these domains, which reflects the existence of a
single underlying construct, Humanistic impact.
Low to moderate correlations (0.10 to 0.60) between
SCQ domain scores and SF-36 domain scores were ob-
served (Table 3). Scores pertaining to humanistic im-
pact showed moderate correlations with ‘Vitality’, ‘Social
Functioning’, ‘Mental Health’ domain scores and Mental
Component Score (MCS), and low correlation with the
other SF-36 scores related to Physical Functioning or
Pain. The score ‘Worries for the patient’ also had moderate
correlation with the scores assessing mental health (‘Mental
health’ and MCS).
Low correlations were observed between SCQ domain
scores and the PANSS and PSP domain scores (-0.24 to
0.31) (Table 3).
The severity of schizophrenia perceived by the caregiver
(CaGI-S) was associated with all SCQ domain scores
(p < 0.001), with higher mean scores when the disease
was rated as more severe (Fig. 3). Similar findings were
observed when comparing SCQ scores to the level of se-
verity of schizophrenia assessed using the CGI-S (data not
shown).
Ability to detect change
For all domains except ‘Financial dependence of the pa-
tient’, SCQ scores decreased for caregivers of patients
whose schizophrenia improved and increased for care-
givers of patients whose schizophrenia worsened. (Fig. 3)
Fig. 2 Person-item distribution of SCQ items of the Humanistic impact from the Rating Scale Model with items scored with 5 categories at
baseline (N = 358)
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Table 2 Description of SCQ scores, reliability, item convergent and discriminant validity, and meaningfulness














SD  ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1−αð Þp Mean change Mean change
HI-TS 17 27.8 (23.4) 0.96 0.87 - - - 5.13 -3.96 7.67
HI-P 3 27.0 (27.3) 0.85 0.82 0.62-0.75 100 % 33 % 11.09 -6.75 10.42
HI-E 6 30.0 (24.8) 0.89 0.81 0.63-0.75 100 % 83 % 8.59 -2.23 8.78
HI-S 3 26.4 (26.1) 0.80 0.75 0.60-0.66 100 % 0 % 12.21 -3.16 1.49
HI-DL 5 26.5 (24.3) 0.87 0.81 0.59-0.76 100 % 40 % 9.26 -4.83 8.39
EC 2 19.9 (24.7) 0.69 0.76 0.49 100 % 100 % 14.37 -0.86 3.13
FA 1 32.0 (36.0) NA 0.63 NA NA NA NA -6.90 8.04
PD 2 36.7 (27.5) 0.57 0.75 0.37 0 % 0 % 18.64 -8.62 6.25
WP 2 42.0 (28.7) 0.70 0.75 0.54-0.71 100 % 100 % 12.93 -7.04 6.55
PC 3 34.0 (29.9) 0.79 0.71 0.71 100 % 100 % 12.45 -1.29 4.02
FDP 1 37.9 (39.6) NA 0.70 NA NA NA NA -8.62 -2.68
FIC 1 26.0 (32.1) NA 0.75 NA NA NA NA 0.86 1.79
ODC 1 28.6 (31.6) NA 0.75 NA NA NA NA -6.90 16.96
SD Standard deviation; α = reliability coefficient (Cronbach’s α); ICC Intraclass correlation coefficient, NA not applicable as single-item dimension, HI-TS Humanistic impact – total score, HI-P Humanistic impact - Physical,
HI-E Humanistic impact - Emotional, HI-S Humanistic impact - Social, HI-DL Humanistic impact - Daily life, EC Exhaustion with caregiving, FA Feeling alone, PD Patient Dependence, WP Worries for the patient, PC Perception of
caregiving, FDP Financial dependence of the patient, FIC Financial impact of caregiving, ODC Overall difficulty of caregiving
Description of SCQ scores, internal consistency reliability and item convergent and discriminant validity data were obtained at baseline in the caregiver analysis set (N = 358). Test-retest reliability data were obtained
between baseline and month 3 in caregivers whose patient’s severity was stable between the two assessments (N = 147). Analyses supporting meaningful change in SCQ domain scores were calculated using
distribution-based methods at baseline in the caregiver analysis set (N = 358) and anchor-based methods in patients minimally improved at Month 6 (N = 58) and patients minimally worsened (N = 28)
*Reliability coefficient is considered acceptable if > 0.70
aRange of correlations between each item and its domain score
bItem convergent validity criterion: correlation between an item and its domain score should be ≥0.40










The increase was particularly visible in the scores per-
taining to Humanistic impact. Overall, this pattern of
results supports the ability of the SCQ to detect changes
in the caregiver experience.
Interpretation of SCQ scores
Meaningful change for SCQ domain scores estimated using
both distribution-based and anchor-based methods are pre-
sented in Table 2. The distribution-based values ranged
from 5.1 to 19.8. Anchor-based values, obtained using the
severity of the patient’s schizophrenia assessed using the
CaGI as an anchor, ranged between 0.86 and -8.62 for im-
provement and -2.68 and 16.96 for worsening. However,
these anchor-based values should be interpreted cau-
tiously because, for some domains such as financial
aspects or perception of care provided, the anchor
used (patient schizophrenia severity) is likely not well
correlated with the actual impact on the caregiver,
making the resulting value not appropriate.
Discussion
The objective of this study was to create a scoring algo-
rithm and assess the measurement properties of the
SCQ, a newly developed instrument to assess the impact
of caregiving for a person with schizophrenia from the
perspectives of caregivers. The SCQ scoring algorithm was
developed using the a priori conceptual model of the SCQ
from the qualitative research phase [13] and empirical
results from the observational PATTERN study. Ana-
lyses revealed two distinct constructs assessed by the
SCQ: ‘Humanistic impact,’ comprising the social, emo-
tional, daily life and physical impact on the individual
caregiver; and aspects related to the caregiving role,
such as perceptions of the caregiver towards caregiving
(e.g. feeling alone, dependence of the patient, or ex-
haustion with caregiving) or financial aspects.
The measurement properties (reliability, validity and
ability to detect change) demonstrated by the SCQ in
the PATTERN study were excellent. The SCQ showed
good reliability, with most reliability coefficients above
the recommended threshold of 0.7 [24]. SCQ construct
validity was consistently supported. Firstly, item conver-
gent and divergent validity was fully satisfactory; only the
subdomain scores within the Humanistic impact supra-
domain showed imperfect item divergent validity. This
may have been due to their relationship with the common
underlying concept Humanistic impact. However, in order
to document salient aspects of the impact of caregiving on
caregivers these subdomains were retained. Secondly, pa-
tients with more severe symptoms of schizophrenia ac-
cording to the clinicians’ overall severity rating were
consistently associated with higher SCQ scores indicating
more impact for the caregiver. Thirdly, an expected pat-
tern of association was found between SCQ scores and
other measures of severity of patient’s schizophrenia and
caregiver HRQL. In particular, the salience of the psycho-
logical and social aspects of caregiving were marked by
the the highest observed correlations between the mea-
sures of the Humanistic impact (including subdomain
scores) and the SF-36 score pertaining to the mental and
Table 3 Concurrent validity - Pearson correlation coefficients between the SCQ domains and the concurrent questionnaires (SF-36, PANSS
and PSP) at baseline in the caregiver analysis set (N= 358)
SCQ domains
Scales Domains HI-TS HI-P HI-E HI-S HI-DL ODC PD PC EC FA FDP FIC WP
SF-36 Physical Functioning -0.22 -0.21 -0.19 -0.24 -0.20 -0.15 -0.20 -0.07 -0.15 -0.11 -0.11 -0.23 -0.21
Role Physical -0.20 -0.20 -0.15 -0.22 -0.20 -0.16 -0.15 -0.11 -0.17 -0.08 -0.06 -0.20 -0.18
Bodily Pain -0.24 -0.23 -0.21 -0.22 -0.22 -0.16 -0.17 -0.14 -0.12 -0.10 -0.10 -0.22 -0.27
General Health Perceptions -0.39 -0.39 -0.34 -0.37 -0.36 -0.27 -0.18 -0.20 -0.29 -0.23 -0.12 -0.25 -0.34
Vitality -0.46 -0.45 -0.40 -0.43 -0.45 -0.34 -0.24 -0.23 -0.31 -0.29 -0.15 -0.25 -0.38
Social Functioning -0.43 -0.43 -0.37 -0.41 -0.41 -0.33 -0.23 -0.29 -0.33 -0.25 -0.19 -0.32 -0.37
Role Emotional -0.41 -0.38 -0.38 -0.37 -0.39 -0.28 -0.20 -0.26 -0.29 -0.21 -0.14 -0.28 -0.31
Mental Health -0.56 -0.51 -0.53 -0.51 -0.51 -0.42 -0.32 -0.26 -0.37 -0.32 -0.20 -0.37 -0.51
PCS -0.15 -0.16 -0.11 -0.17 -0.14 -0.10 -0.13 -0.07 -0.11 -0.06 -0.06 -0.17 -0.17
MCS -0.56 -0.53 -0.52 -0.50 -0.53 -0.42 -0.27 -0.32 -0.39 -0.33 -0.20 -0.34 -0.46
PANSS Positive symptoms 0.31 0.26 0.31 0.27 0.30 0.27 0.29 0.17 0.28 0.25 0.18 0.24 0.24
Negative symptoms 0.22 0.19 0.19 0.19 0.25 0.21 0.24 0.07 0.24 0.11 0.16 0.24 0.19
PSP PSP total -0.21 -0.18 -0.16 -0.22 -0.24 -0.23 -0.21 -0.11 -0.16 -0.10 -0.17 -0.17 -0.11
PSP Personal and Social Performance Scale, PANSS Positive and Negative Syndrome Scale, HI-TS Humanistic impact – total score, HI-P Humanistic impact - Physical,
HI-E Humanistic impact - Emotional, HI-S Humanistic impact - Social, HI-DL Humanistic impact - Daily life, ODC Overall difficulty of caregiving, PD Patient Dependence,
PC Perception of caregiving, EC Exhaustion with caregiving, FA Feeling alone, FDP Financial dependence of the patient, FIC Financial impact of caregiving, WP Worries for
the patient
Pearson's correlations; In bold, 0.40 < correlations < 0.60
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Fig. 3 Measurement properties of SCQ: a Clinical validity - comparison of the SCQ domain scores according to CaGI-S at baseline in the caregiver
analysis set (N = 358); b Ability to detect change - comparison of the change in SCQ domain scores according to CaGI-I between baseline and
6 months in patients with SCQ data at baseline and Month 6 (N = 270)
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social aspects. In addition, the correlations between these
SCQ scores and the SF-36 ‘Vitality’ score may reflect the
critical role of tiredness on the impact on caregivers of pa-
tients with schizophrenia [7]. Finally, most SCQ scores
demonstrated clear changes as the patient’s schizophrenia
symptoms increased in severity and, a more subtle change,
when symptoms of schizophrenia improved. These results
demonstrate that changes in the patient’s symptoms of
schizophrenia could also translate into changes on the im-
pact on their caregiver. Based on these findings, an inter-
esting follow-up analysis would be to further explore the
association between the change in severity of schizophre-
nia symptoms and impact on the caregivers, by studying
the association between the SCQ scores and changes in
measures of schizophrenia symptoms such as the PANSS.
PATTERN data also offered an opportunity to generate
preliminary information to guide interpretation of the SCQ
scores. Changes of between 9 and 13 points for the subdo-
mains of the humanistic impact supra-domain and slightly
lower (about 6 or 7) for the Humanistic impact - Total
score appeared to be meaningful. Interestingly, the anchor-
based method suggested different values for improvement
and worsening. Importantly, these results should be inter-
preted with caution as 1) they were obtained either using a
distribution-based approach or using the severity of patient
schizophrenia symptoms (and not a true assessment of the
change in the caregiver experience) as an anchor, and 2)
were obtained with a fairly small number of caregivers.
Further results will be needed to consolidate the guidance
for the interpretation of SCQ scores.
Some instruments were already available to assess the
impact on caregivers of patients with schizophrenia: the
Schizophrenia Caregiver Quality of Life questionnaire
(SCGQoL) [25], the Experience of Caregiving Inventory
(ECI) [26] and the Involvement Evaluation Question-
naire (IEQ) [27]. However, the SCQ has several advan-
tages in comparison as it builds on the ZBI, which is a
widely-used standard assessment of caregiver impact,
and followed questionnaire development best-practices
beginning with qualitative research involving a substan-
tial number of caregivers of patients with schizophrenia
[13]. In addition, the SCQ demonstrated strong, reliable
measurement properties possibly as a result of psycho-
metrically sound questionnaire development. While
the SCQ may focus on the level of negative impacts a
caregiver can experience, a specific instrument as for
example the Scale for Positive Aspects of Caregiving
Experience (SPACE) [28] could be used to assess positive
aspects of care in schizophrenia and thus provide a com-
prehensive picture of caregiver experience. Finally, the
SCQ is also available in a number of language versions,
which have been obtained through a high standard of
linguistic validation [14], and could be used to facilitate
research in multinational settings.
Some remarkable findings on the SCQ may deserve
further attention in the future. First, the SCQ may not
be able to accurately measure when only a very mild or
no impact is experienced by some caregivers. This was
shown by Rasch modeling and consistent floor effects
observed for all items of the questionnaire. This may
present an issue if the questionnaire is administered to
caregivers experiencing only mild impact of caregiving.
The SCQ may also under-identify improvement in the
impact on the caregiver when the baseline impact is
already minor. Further research may be needed to iden-
tify the markers of the mild impact of caregiving, which
could be useful in developing items allowing better
assessment for caregivers with mild caregiving impact.
Secondly, the SCQ response scale was modified com-
pared to the ZBI from a 5-point response scale to an 11-
point Numeric Rating Scale (NRS). Our analyses led to
the definition of SCQ scores based on recoding of the
11-point response scales into 5 categories. As the SCQ
includes both items measuring frequency, which are
probably most naturally assessed with a 5-point response
scale, and items measuring intensity, for which an 11-
point NRS may be more appropriate, using an 11-point
NRS and recoding the responses at the scoring stage is
still a valid option in order to use a consistent response
scale throughout the instrument.
The PATTERN study was an observational study pri-
marily designed to assess the course of symptoms of
schizophrenia, with the caregiver component of the
study as an ancillary study. Due to this, the information
on caregivers who completed the questionnaire was
only partial, making the characterization of the analysis
sample less accurate than generally expected. This also
prevented the analysis of Differential Item Functioning
(DIF) for the SCQ items in terms of gender, age or relation
with the patient (i.e., parent, spouse or sibling) of the care-
giver. In addition, no natural “anchor” was collected to
characterize the change in the caregiver experience, result-
ing in a less robust detection in change in caregiving im-
pacts, since it relied only on the change in the patient’s
overall health status. Finally, the electronic data collection
method ensured the completion of the SCQ items and
therefore any information on the understanding and rele-
vance of the items potentially showed by non-response
could not be captured. All these questions would be worth
exploring in future research.
Conclusions
The SCQ was shown to be an instrument allowing the
comprehensive assessment of the experience of care-
givers of patients with schizophrenia through 30 items
that allow the calculation of 9 multi-item scores and 4
single item scores that all demonstrated very good meas-
urement properties. This new algorithm should offer an
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approach to describe the diverse aspects of caregiver’s
experience. The care for patients with schizophrenia
relies more and more heavily on informal caregivers.
Hence, the assessment of the impact of schizophrenia, and
of any intervention linked to management of patients
should be holistic. Such a holistic approach would only
be complete with perspectives from the patient’s social
ecology, which necessarily involves the caregivers. The
SCQ, as a schizophrenia specific measure of caregiver
impact, will be an instrument of choice in this context
and should therefore be extremely useful in future
schizophrenia studies.
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